25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HansBiomed Corporation
Buy, Hold or Sell?

Let's analyze Hansbiomed together

I guess you are interested in HansBiomed Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of HansBiomed Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about HansBiomed Corporation

I send you an email if I find something interesting about HansBiomed Corporation.

1. Quick Overview

1.1. Quick analysis of Hansbiomed (30 sec.)










1.2. What can you expect buying and holding a share of Hansbiomed? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
₩5,708.60
Expected worth in 1 year
₩6,885.39
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
₩1,176.79
Return On Investment
13.3%

For what price can you sell your share?

Current Price per Share
₩8,850.00
Expected price per share
₩6,500 - ₩11,870
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Hansbiomed (5 min.)




Live pricePrice per Share (EOD)
₩8,850.00
Intrinsic Value Per Share
₩-5,595.21 - ₩8,709.51
Total Value Per Share
₩113.39 - ₩14,418.11

2.2. Growth of Hansbiomed (5 min.)




Is Hansbiomed growing?

Current yearPrevious yearGrowGrow %
How rich?$51.8m$36.6m$10.5m22.4%

How much money is Hansbiomed making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$1.7m$62.8k3.8%
Net Profit Margin-12.4%-11.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Hansbiomed (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Hansbiomed?

Welcome investor! Hansbiomed's management wants to use your money to grow the business. In return you get a share of Hansbiomed.

First you should know what it really means to hold a share of Hansbiomed. And how you can make/lose money.

Speculation

The Price per Share of Hansbiomed is ₩8,850. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hansbiomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hansbiomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩5,708.60. Based on the TTM, the Book Value Change Per Share is ₩294.20 per quarter. Based on the YOY, the Book Value Change Per Share is ₩316.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hansbiomed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.010.0%-0.130.0%-0.120.0%-0.130.0%-0.030.0%
Usd Book Value Change Per Share0.090.0%0.210.0%0.220.0%0.010.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.0%
Usd Total Gains Per Share0.090.0%0.210.0%0.220.0%0.010.0%0.050.0%
Usd Price Per Share8.18-10.14-9.65-10.94-13.12-
Price to Earnings Ratio404.76--125.77--41.55--20.77-9.58-
Price-to-Total Gains Ratio94.09--40.58--246.67-58.72-93.27-
Price to Book Ratio2.05-2.94-3.34-3.45-4.42-
Price-to-Total Gains Ratio94.09--40.58--246.67-58.72-93.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.195
Number of shares161
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.210.01
Usd Total Gains Per Share0.210.01
Gains per Quarter (161 shares)33.161.89
Gains per Year (161 shares)132.627.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1013312325-2
202652564116
3039838961614
4053052282222
50663655102730
60796788123338
70928921143846
8010611054164454
9011941187184962
10013261320215570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%26.014.00.065.0%29.014.00.067.4%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%9.011.00.045.0%26.014.00.065.0%29.014.00.067.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%10.00.030.025.0%10.00.033.023.3%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%10.010.00.050.0%27.013.00.067.5%30.013.00.069.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of HansBiomed Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--124.134294.198-58%316.116-61%12.171+920%65.684+89%
Book Value Per Share--5708.5995195.243+10%4033.357+42%4581.292+25%4350.712+31%
Current Ratio--1.1001.032+7%0.797+38%1.362-19%1.040+6%
Debt To Asset Ratio--0.4070.448-9%0.591-31%0.552-26%0.400+2%
Debt To Equity Ratio--0.6880.872-21%1.507-54%1.359-49%0.856-20%
Dividend Per Share----0%-0%4.557-100%11.574-100%
Enterprise Value--100868873520.000133460384337.500-24%110012696542.500-8%147752097424.500-32%206817033398.250-51%
Eps--7.214-182.735+2633%-174.537+2519%-189.583+2728%-36.945+612%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--1.2121.665-27%1.420-15%2.041-41%4.537-73%
Free Cash Flow Per Share---49.242-18.574-62%-125.030+154%-179.918+265%-196.663+299%
Free Cash Flow To Equity Per Share---49.242-18.574-62%-197.632+301%93.121-153%115.386-143%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8709.515--------
Intrinsic Value_10Y_min---5595.208--------
Intrinsic Value_1Y_max---372.979--------
Intrinsic Value_1Y_min---753.081--------
Intrinsic Value_3Y_max---171.257--------
Intrinsic Value_3Y_min---2109.463--------
Intrinsic Value_5Y_max--1175.056--------
Intrinsic Value_5Y_min---3287.508--------
Market Cap114934950000.000-32%151688160000.000188214097500.000-19%178993327500.000-15%203012784000.000-25%243405600750.000-38%
Net Profit Margin--0.005-0.124+2855%-0.119+2747%-0.141+3238%0.005-14%
Operating Margin----0%-0.0100%-0.0630%0.017-100%
Operating Ratio--1.3441.416-5%1.164+15%0.863+56%0.852+58%
Pb Ratio1.550-32%2.0462.940-30%3.345-39%3.445-41%4.419-54%
Pe Ratio306.690-32%404.762-125.770+131%-41.548+110%-20.774+105%9.576+4127%
Price Per Share8850.000-32%11680.00014492.500-19%13782.500-15%15632.000-25%18742.250-38%
Price To Free Cash Flow Ratio-44.931+24%-59.29920.932-383%-31.772-46%-45.604-23%414.555-114%
Price To Total Gains Ratio71.294-32%94.092-40.582+143%-246.667+362%58.720+60%93.267+1%
Quick Ratio--0.2630.257+3%0.318-17%0.904-71%1.063-75%
Return On Assets--0.001-0.019+2691%-0.020+2714%-0.019+2690%0.001-41%
Return On Equity--0.001-0.047+3781%-0.042+3417%-0.048+3854%-0.009+808%
Total Gains Per Share--124.134294.198-58%316.116-61%16.727+642%77.258+61%
Usd Book Value--51896302.61247229433.991+10%36666845.313+42%41648067.279+25%39551886.190+31%
Usd Book Value Change Per Share--0.0870.206-58%0.221-61%0.009+920%0.046+89%
Usd Book Value Per Share--3.9963.637+10%2.823+42%3.207+25%3.045+31%
Usd Dividend Per Share----0%-0%0.003-100%0.008-100%
Usd Enterprise Value--70608211.46493422269.036-24%77008887.580-8%103426468.197-32%144771923.379-51%
Usd Eps--0.005-0.128+2633%-0.122+2519%-0.133+2728%-0.026+612%
Usd Free Cash Flow---447653.556-168852.065-62%-1136634.907+154%-1635615.764+265%-1743146.074+289%
Usd Free Cash Flow Per Share---0.034-0.013-62%-0.088+154%-0.126+265%-0.138+299%
Usd Free Cash Flow To Equity Per Share---0.034-0.013-62%-0.138+301%0.065-153%0.081-143%
Usd Market Cap80454465.000-32%106181712.000131749868.250-19%125295329.250-15%142108948.800-25%170383920.525-38%
Usd Price Per Share6.195-32%8.17610.145-19%9.648-15%10.942-25%13.120-38%
Usd Profit--65582.846-1661227.292+2633%-1724084.437+2729%-1750956.320+2770%-349599.717+633%
Usd Revenue--14570127.67714111753.838+3%13748140.998+6%12949620.251+13%10154815.085+43%
Usd Total Gains Per Share--0.0870.206-58%0.221-61%0.012+642%0.054+61%
 EOD+3 -5MRQTTM+19 -16YOY+22 -135Y+23 -1410Y+21 -17

3.3 Fundamental Score

Let's check the fundamental score of HansBiomed Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15306.690
Price to Book Ratio (EOD)Between0-11.550
Net Profit Margin (MRQ)Greater than00.005
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.263
Current Ratio (MRQ)Greater than11.100
Debt to Asset Ratio (MRQ)Less than10.407
Debt to Equity Ratio (MRQ)Less than10.688
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.001
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of HansBiomed Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.690
Ma 20Greater thanMa 507,938.500
Ma 50Greater thanMa 1008,151.400
Ma 100Greater thanMa 2009,197.300
OpenGreater thanClose8,700.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About HansBiomed Corporation

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. The company was founded in 1990 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 16:27:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Hansbiomed earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Hansbiomed to the Medical Devices industry mean.
  • A Net Profit Margin of 0.5% means that ₩0.00 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HansBiomed Corporation:

  • The MRQ is 0.5%. The company is not making a profit/loss.
  • The TTM is -12.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ0.5%TTM-12.4%+12.9%
TTM-12.4%YOY-11.9%-0.5%
TTM-12.4%5Y-14.1%+1.7%
5Y-14.1%10Y0.5%-14.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%-6.4%+6.9%
TTM-12.4%-14.8%+2.4%
YOY-11.9%-16.4%+4.5%
5Y-14.1%-17.9%+3.8%
10Y0.5%-20.9%+21.4%
4.3.1.2. Return on Assets

Shows how efficient Hansbiomed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hansbiomed to the Medical Devices industry mean.
  • 0.1% Return on Assets means that Hansbiomed generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HansBiomed Corporation:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-1.9%+2.0%
TTM-1.9%YOY-2.0%+0.0%
TTM-1.9%5Y-1.9%0.0%
5Y-1.9%10Y0.1%-2.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-2.3%+2.4%
TTM-1.9%-3.1%+1.2%
YOY-2.0%-4.0%+2.0%
5Y-1.9%-3.0%+1.1%
10Y0.1%-4.0%+4.1%
4.3.1.3. Return on Equity

Shows how efficient Hansbiomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hansbiomed to the Medical Devices industry mean.
  • 0.1% Return on Equity means Hansbiomed generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HansBiomed Corporation:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -4.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-4.7%+4.8%
TTM-4.7%YOY-4.2%-0.5%
TTM-4.7%5Y-4.8%+0.1%
5Y-4.8%10Y-0.9%-3.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-2.7%+2.8%
TTM-4.7%-3.8%-0.9%
YOY-4.2%-4.6%+0.4%
5Y-4.8%-4.0%-0.8%
10Y-0.9%-5.3%+4.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of HansBiomed Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Hansbiomed is operating .

  • Measures how much profit Hansbiomed makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hansbiomed to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HansBiomed Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1.0%+1.0%
TTM-5Y-6.3%+6.3%
5Y-6.3%10Y1.7%-8.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.1%+13.1%
TTM--20.7%+20.7%
YOY-1.0%-13.7%+12.7%
5Y-6.3%-16.8%+10.5%
10Y1.7%-22.1%+23.8%
4.3.2.2. Operating Ratio

Measures how efficient Hansbiomed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are ₩1.34 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of HansBiomed Corporation:

  • The MRQ is 1.344. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.416. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.344TTM1.416-0.072
TTM1.416YOY1.164+0.252
TTM1.4165Y0.863+0.553
5Y0.86310Y0.852+0.011
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3441.202+0.142
TTM1.4161.297+0.119
YOY1.1641.328-0.164
5Y0.8631.361-0.498
10Y0.8521.306-0.454
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of HansBiomed Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Hansbiomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.10 means the company has ₩1.10 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of HansBiomed Corporation:

  • The MRQ is 1.100. The company is just able to pay all its short-term debts.
  • The TTM is 1.032. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.100TTM1.032+0.068
TTM1.032YOY0.797+0.235
TTM1.0325Y1.362-0.330
5Y1.36210Y1.040+0.323
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1002.574-1.474
TTM1.0322.722-1.690
YOY0.7972.894-2.097
5Y1.3623.449-2.087
10Y1.0403.545-2.505
4.4.3.2. Quick Ratio

Measures if Hansbiomed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hansbiomed to the Medical Devices industry mean.
  • A Quick Ratio of 0.26 means the company can pay off ₩0.26 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HansBiomed Corporation:

  • The MRQ is 0.263. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.257. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.263TTM0.257+0.007
TTM0.257YOY0.318-0.061
TTM0.2575Y0.904-0.648
5Y0.90410Y1.063-0.159
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2631.449-1.186
TTM0.2571.674-1.417
YOY0.3181.903-1.585
5Y0.9042.331-1.427
10Y1.0632.551-1.488
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of HansBiomed Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Hansbiomed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hansbiomed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.41 means that Hansbiomed assets are financed with 40.7% credit (debt) and the remaining percentage (100% - 40.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HansBiomed Corporation:

  • The MRQ is 0.407. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.448. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.407TTM0.448-0.041
TTM0.448YOY0.591-0.143
TTM0.4485Y0.552-0.104
5Y0.55210Y0.400+0.152
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4070.404+0.003
TTM0.4480.400+0.048
YOY0.5910.360+0.231
5Y0.5520.430+0.122
10Y0.4000.452-0.052
4.5.4.2. Debt to Equity Ratio

Measures if Hansbiomed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hansbiomed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 68.8% means that company has ₩0.69 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HansBiomed Corporation:

  • The MRQ is 0.688. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.872. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.688TTM0.872-0.183
TTM0.872YOY1.507-0.635
TTM0.8725Y1.359-0.488
5Y1.35910Y0.856+0.503
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6880.565+0.123
TTM0.8720.598+0.274
YOY1.5070.532+0.975
5Y1.3590.633+0.726
10Y0.8560.712+0.144
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Hansbiomed generates.

  • Above 15 is considered overpriced but always compare Hansbiomed to the Medical Devices industry mean.
  • A PE ratio of 404.76 means the investor is paying ₩404.76 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HansBiomed Corporation:

  • The EOD is 306.690. Based on the earnings, the company is expensive. -2
  • The MRQ is 404.762. Based on the earnings, the company is expensive. -2
  • The TTM is -125.770. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD306.690MRQ404.762-98.072
MRQ404.762TTM-125.770+530.531
TTM-125.770YOY-41.548-84.221
TTM-125.7705Y-20.774-104.995
5Y-20.77410Y9.576-30.350
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD306.690-0.974+307.664
MRQ404.762-1.351+406.113
TTM-125.770-1.813-123.957
YOY-41.548-2.356-39.192
5Y-20.774-2.196-18.578
10Y9.576-1.929+11.505
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HansBiomed Corporation:

  • The EOD is -44.931. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -59.299. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 20.932. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-44.931MRQ-59.299+14.368
MRQ-59.299TTM20.932-80.231
TTM20.932YOY-31.772+52.704
TTM20.9325Y-45.604+66.536
5Y-45.60410Y414.555-460.160
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-44.931-1.523-43.408
MRQ-59.299-2.004-57.295
TTM20.932-2.233+23.165
YOY-31.772-5.467-26.305
5Y-45.604-4.010-41.594
10Y414.555-4.841+419.396
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Hansbiomed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.05 means the investor is paying ₩2.05 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of HansBiomed Corporation:

  • The EOD is 1.550. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.046. Based on the equity, the company is underpriced. +1
  • The TTM is 2.940. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.550MRQ2.046-0.496
MRQ2.046TTM2.940-0.894
TTM2.940YOY3.345-0.405
TTM2.9405Y3.445-0.505
5Y3.44510Y4.419-0.973
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.5502.123-0.573
MRQ2.0462.188-0.142
TTM2.9402.363+0.577
YOY3.3452.835+0.510
5Y3.4454.045-0.600
10Y4.4194.510-0.091
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Net Income  -415,944-8,095,776-8,511,7217,489,009-1,022,712970,727-51,985145,67493,690



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets124,956,862
Total Liabilities50,819,286
Total Stockholder Equity73,844,804
 As reported
Total Liabilities 50,819,286
Total Stockholder Equity+ 73,844,804
Total Assets = 124,956,862

Assets

Total Assets124,956,862
Total Current Assets50,492,192
Long-term Assets74,464,670
Total Current Assets
Cash And Cash Equivalents 8,024,399
Net Receivables 12,086,640
Inventory 27,039,442
Other Current Assets 2,295,700
Total Current Assets  (as reported)50,492,192
Total Current Assets  (calculated)49,446,181
+/- 1,046,011
Long-term Assets
Property Plant Equipment 44,129,985
Intangible Assets 700,959
Long-term Assets Other 0
Long-term Assets  (as reported)74,464,670
Long-term Assets  (calculated)44,830,945
+/- 29,633,725

Liabilities & Shareholders' Equity

Total Current Liabilities45,908,842
Long-term Liabilities4,910,445
Total Stockholder Equity73,844,804
Total Current Liabilities
Short Long Term Debt 31,300,000
Accounts payable 1,921,735
Other Current Liabilities 159,053
Total Current Liabilities  (as reported)45,908,842
Total Current Liabilities  (calculated)33,380,788
+/- 12,528,053
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,426,562
Long-term Liabilities  (as reported)4,910,445
Long-term Liabilities  (calculated)2,426,562
+/- 2,483,883
Total Stockholder Equity
Total Stockholder Equity (as reported)73,844,804
Total Stockholder Equity (calculated)0
+/- 73,844,804
Other
Capital Stock6,763,184
Common Stock Shares Outstanding 12,987
Net Debt 23,275,601
Net Invested Capital 105,144,804
Net Working Capital 4,583,350
Property Plant and Equipment Gross 44,129,986



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
> Total Assets 
41,911,863
41,918,401
43,606,701
44,341,826
45,285,509
47,635,625
49,844,502
52,112,309
53,317,829
59,334,064
61,262,360
64,717,087
73,834,725
77,496,068
81,687,479
80,190,379
81,698,299
90,975,031
90,788,163
91,797,718
93,682,395
91,670,092
125,407,157
134,094,823
136,982,792
136,534,688
140,390,481
131,806,491
151,838,805
144,672,781
147,462,137
129,444,534
143,310,910
140,138,301
132,613,734
131,686,206
127,904,171
127,468,815
125,682,031
122,367,958
120,681,424
120,891,089
124,956,862
124,956,862120,891,089120,681,424122,367,958125,682,031127,468,815127,904,171131,686,206132,613,734140,138,301143,310,910129,444,534147,462,137144,672,781151,838,805131,806,491140,390,481136,534,688136,982,792134,094,823125,407,15791,670,09293,682,39591,797,71890,788,16390,975,03181,698,29980,190,37981,687,47977,496,06873,834,72564,717,08761,262,36059,334,06453,317,82952,112,30949,844,50247,635,62545,285,50944,341,82643,606,70141,918,40141,911,863
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,842,702
27,283,906
28,669,146
35,904,181
35,643,753
37,284,096
37,967,464
35,713,332
59,261,345
58,785,348
60,785,201
59,337,777
62,157,431
58,695,729
78,629,875
70,841,040
73,574,842
51,113,063
64,895,806
62,770,645
56,030,861
54,371,071
51,935,393
52,231,133
51,231,643
50,392,855
50,318,718
47,916,954
50,492,192
50,492,19247,916,95450,318,71850,392,85551,231,64352,231,13351,935,39354,371,07156,030,86162,770,64564,895,80651,113,06373,574,84270,841,04078,629,87558,695,72962,157,43159,337,77760,785,20158,785,34859,261,34535,713,33237,967,46437,284,09635,643,75335,904,18128,669,14627,283,90627,842,70200000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,903,908
4,721,047
5,463,078
12,882,919
9,793,549
8,564,603
6,743,463
4,379,861
7,096,249
4,034,652
10,707,227
9,848,270
10,842,528
9,346,838
31,376,975
16,691,063
9,853,584
3,551,105
8,300,973
0
0
15
7,543,608
6,974,028
6,510,213
6,131,608
6,760,068
7,651,731
8,024,399
8,024,3997,651,7316,760,0686,131,6086,510,2136,974,0287,543,60815008,300,9733,551,1059,853,58416,691,06331,376,9759,346,83810,842,5289,848,27010,707,2274,034,6527,096,2494,379,8616,743,4638,564,6039,793,54912,882,9195,463,0784,721,0476,903,90800000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000,000
0
0
0
0
0
0
0
11,570,831
24,492,311
30,899,809
13,217,088
24,224,064
21,464,800
12,638,328
7,456,069
4,770,235
2,795,025
1,450,557
916,256
483,899
0
0
00483,899916,2561,450,5572,795,0254,770,2357,456,06912,638,32821,464,80024,224,06413,217,08830,899,80924,492,31111,570,83100000002,000,00000000000000000000000
       Net Receivables 
7,366,279
6,647,883
7,621,922
7,955,359
8,085,678
8,209,765
8,798,622
9,050,550
8,715,803
10,230,724
10,771,947
11,057,324
11,620,345
10,253,613
11,376,565
11,754,273
12,559,886
11,048,101
13,695,217
15,354,915
15,847,211
17,323,450
16,746,671
13,820,240
14,478,935
14,766,431
15,083,686
15,463,458
15,258,746
10,077,499
11,065,902
9,803,369
7,310,475
7,865,184
9,234,749
10,223,423
10,415,847
11,701,123
10,906,884
12,090,726
12,424,357
11,658,172
12,086,640
12,086,64011,658,17212,424,35712,090,72610,906,88411,701,12310,415,84710,223,4239,234,7497,865,1847,310,4759,803,36911,065,90210,077,49915,258,74615,463,45815,083,68614,766,43114,478,93513,820,24016,746,67117,323,45015,847,21115,354,91513,695,21711,048,10112,559,88611,754,27311,376,56510,253,61311,620,34511,057,32410,771,94710,230,7248,715,8039,050,5508,798,6228,209,7658,085,6787,955,3597,621,9226,647,8837,366,279
       Other Current Assets 
95,482
94,073
52,461
49,972
107,107
319,770
283,281
322,376
206,199
226,442
197,614
178,041
1,244,882
678,810
497,654
750,271
713,416
730,156
977,193
306,338
1,282,638
471,696
1,445,126
412,451
3,868,799
4,036,829
3,616,467
1,552,949
3,139,790
2,786,824
2,666,299
1,935,228
1,690,597
1,951,137
5,143,922
3,078,634
2,324,249
1,544,460
1,725,872
441,220
2,044,646
2,414,517
2,295,700
2,295,7002,414,5172,044,646441,2201,725,8721,544,4602,324,2493,078,6345,143,9221,951,1371,690,5971,935,2282,666,2992,786,8243,139,7901,552,9493,616,4674,036,8293,868,799412,4511,445,126471,6961,282,638306,338977,193730,156713,416750,271497,654678,8101,244,882178,041197,614226,442206,199322,376283,281319,770107,10749,97252,46194,07395,482
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,968,778
75,237,682
74,450,388
71,975,103
70,362,706
72,974,135
74,464,670
74,464,67072,974,13570,362,70671,975,10374,450,38875,237,68275,968,778000000000000000000000000000000000000
       Property Plant Equipment 
13,862,878
13,955,495
24,228,799
24,696,749
24,119,912
24,294,481
25,669,993
28,436,895
29,825,963
32,009,008
33,318,220
36,374,317
43,442,550
47,486,371
48,065,547
26,525,003
26,457,894
26,759,545
27,497,503
25,979,807
27,220,074
28,773,144
38,998,638
44,535,269
44,444,588
46,582,263
47,620,734
47,246,632
47,937,041
48,322,067
48,773,512
46,591,160
47,406,080
47,361,011
47,001,494
46,934,429
46,057,411
45,852,644
45,371,146
44,233,927
43,402,912
43,374,047
44,129,985
44,129,98543,374,04743,402,91244,233,92745,371,14645,852,64446,057,41146,934,42947,001,49447,361,01147,406,08046,591,16048,773,51248,322,06747,937,04147,246,63247,620,73446,582,26344,444,58844,535,26938,998,63828,773,14427,220,07425,979,80727,497,50326,759,54526,457,89426,525,00348,065,54747,486,37143,442,55036,374,31733,318,22032,009,00829,825,96328,436,89525,669,99324,294,48124,119,91224,696,74924,228,79913,955,49513,862,878
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
451,578
1,963,435
1,636,029
1,636,029
0
0
7,703,415
0
0
0
880,576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000880,5760007,703,415001,636,0291,636,0291,963,435451,57800000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
240,000
1,840,234
10,000
1,744,168
1,845,924
100,000
100,000
200,000
200,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000200,000200,000100,000100,0001,845,9241,744,16810,0001,840,234240,00010,00010,00000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
142,500
135,000
301,842
297,497
290,698
282,660
280,422
272,084
268,448
273,163
715,676
307,097
344,288
340,523
2,359,323
2,379,358
2,138,084
10,511,790
8,450,827
8,408,300
2,716,287
3,579,800
3,555,263
3,474,670
1,120,245
1,071,463
1,024,421
946,717
899,801
997,742
897,671
834,412
755,827
774,388
708,740
700,959
700,959708,740774,388755,827834,412897,671997,742899,801946,7171,024,4211,071,4631,120,2453,474,6703,555,2633,579,8002,716,2878,408,3008,450,82710,511,7902,138,0842,379,3582,359,323340,523344,288307,097715,676273,163268,448272,084280,422282,660290,698297,497301,842135,000142,5000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
-1
0
0-101000000000000000000000000000000000000000
> Total Liabilities 
4,713,253
3,193,253
3,590,804
4,952,232
5,595,021
7,179,811
7,849,007
8,954,037
9,953,822
14,731,696
15,596,186
17,204,671
24,127,749
26,047,170
28,991,189
25,167,484
26,317,173
24,930,183
20,790,136
22,199,493
22,862,330
19,035,395
54,430,830
59,213,255
61,676,946
62,231,499
63,821,551
71,470,204
88,743,539
87,576,769
91,211,840
84,993,595
100,542,075
97,090,968
90,180,768
86,052,309
82,458,068
67,878,564
66,827,450
72,419,027
47,410,896
48,365,643
50,819,286
50,819,28648,365,64347,410,89672,419,02766,827,45067,878,56482,458,06886,052,30990,180,76897,090,968100,542,07584,993,59591,211,84087,576,76988,743,53971,470,20463,821,55162,231,49961,676,94659,213,25554,430,83019,035,39522,862,33022,199,49320,790,13624,930,18326,317,17325,167,48428,991,18926,047,17024,127,74917,204,67115,596,18614,731,6969,953,8228,954,0377,849,0077,179,8115,595,0214,952,2323,590,8043,193,2534,713,253
   > Total Current Liabilities 
2,685,708
1,300,085
1,627,559
2,804,727
3,338,290
4,695,963
5,250,397
5,527,050
5,670,608
6,409,102
5,607,314
10,797,180
12,648,306
17,618,066
23,279,205
23,159,324
24,309,013
22,692,466
18,739,472
20,051,101
20,800,170
16,973,235
39,198,792
24,176,777
26,545,822
26,250,167
28,806,814
28,091,960
42,435,460
39,590,627
41,210,159
60,990,829
67,503,579
83,983,560
77,308,020
74,443,342
71,248,089
60,142,333
59,681,968
65,252,588
42,694,734
44,498,992
45,908,842
45,908,84244,498,99242,694,73465,252,58859,681,96860,142,33371,248,08974,443,34277,308,02083,983,56067,503,57960,990,82941,210,15939,590,62742,435,46028,091,96028,806,81426,250,16726,545,82224,176,77739,198,79216,973,23520,800,17020,051,10118,739,47222,692,46624,309,01323,159,32423,279,20517,618,06612,648,30610,797,1805,607,3146,409,1025,670,6085,527,0505,250,3974,695,9633,338,2902,804,7271,627,5591,300,0852,685,708
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,999,700
9,999,700
9,999,700
9,999,700
9,999,700
9,999,700
9,999,700
0
10,000,000
10,000,000
10,000,000
8,000,000
9,300,000
9,585,916
27,565,085
27,576,171
27,300,000
36,300,000
27,300,000
36,300,000
27,300,000
27,300,000
27,300,000
0
0
0
0
0
0
00000027,300,00027,300,00027,300,00036,300,00027,300,00036,300,00027,300,00027,576,17127,565,0859,585,9169,300,0008,000,00010,000,00010,000,00010,000,00009,999,7009,999,7009,999,7009,999,7009,999,7009,999,70019,999,70000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,999,700
9,999,700
9,999,700
9,999,700
9,999,700
9,999,700
9,999,700
0
15,208,491
0
0
0
0
0
0
0
0
0
0
0
0
0
52,026,679
38,311,020
38,863,152
39,449,500
27,300,000
30,300,000
31,300,000
31,300,00030,300,00027,300,00039,449,50038,863,15238,311,02052,026,679000000000000015,208,49109,999,7009,999,7009,999,7009,999,7009,999,7009,999,70019,999,70000000000000000
       Accounts payable 
827,251
443,208
764,639
404,055
737,408
620,740
623,691
717,483
214,152
710,831
953,796
258,019
478,674
669,066
0
215,211
0
374,442
771,896
1,331,959
1,753,005
1,301,530
1,864,513
1,692,880
1,854,545
2,060,325
2,999,153
2,435,330
1,905,622
1,225,462
2,150,006
1,204,309
0
0
1,785,891
1,984,089
865,059
1,160,260
1,675,716
2,113,551
2,062,790
948,007
1,921,735
1,921,735948,0072,062,7902,113,5511,675,7161,160,260865,0591,984,0891,785,891001,204,3092,150,0061,225,4621,905,6222,435,3302,999,1532,060,3251,854,5451,692,8801,864,5131,301,5301,753,0051,331,959771,896374,4420215,2110669,066478,674258,019953,796710,831214,152717,483623,691620,740737,408404,055764,639443,208827,251
       Other Current Liabilities 
1,858,457
856,877
862,920
2,400,672
2,600,882
1,075,223
1,626,706
1,809,567
2,456,456
2,698,271
1,653,518
2,164,161
3,794,632
2,664,000
3,279,505
2,944,413
4,309,313
5,318,324
5,616,652
6,515,813
6,607,861
5,529,108
11,703,385
12,273,964
14,404,211
15,174,334
15,089,086
14,739,117
11,449,721
9,657,393
10,352,512
22,002,071
0
0
21,634,582
17,054,487
16,375,707
381,775
177,588
1,908,595
2,014,892
193,979
159,053
159,053193,9792,014,8921,908,595177,588381,77516,375,70717,054,48721,634,5820022,002,07110,352,5129,657,39311,449,72114,739,11715,089,08615,174,33414,404,21112,273,96411,703,3855,529,1086,607,8616,515,8135,616,6525,318,3244,309,3132,944,4133,279,5052,664,0003,794,6322,164,1611,653,5182,698,2712,456,4561,809,5671,626,7061,075,2232,600,8822,400,672862,920856,8771,858,457
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,522,988
7,736,231
7,145,481
7,166,439
4,716,162
3,866,652
4,910,445
4,910,4453,866,6524,716,1627,166,4397,145,4817,736,2319,522,988000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,040,000
23,596,887
23,863,930
24,885,465
23,733,439
0
24,864,338
25,472,273
25,902,657
14,536,190
23,738,194
1,363,782
1,311,292
1,346,522
1,043,159
0
0
0
0
0
0
0000001,043,1591,346,5221,311,2921,363,78223,738,19414,536,19025,902,65725,472,27324,864,338023,733,43924,885,46523,863,93023,596,8878,040,0000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-19,999,700
-9,999,700
-9,999,700
-9,999,700
-9,999,700
-9,999,700
-9,999,700
0
-10,000,000
-10,000,000
-10,000,000
-8,000,000
-9,300,000
-9,585,916
-27,565,085
-27,576,171
-27,300,000
-36,300,000
-27,300,000
-36,300,000
-27,300,000
-27,300,000
-25,387,396
2,021,888
1,880,659
1,691,393
1,405,440
1,489,984
2,426,562
2,426,5621,489,9841,405,4401,691,3931,880,6592,021,888-25,387,396-27,300,000-27,300,000-36,300,000-27,300,000-36,300,000-27,300,000-27,576,171-27,565,085-9,585,916-9,300,000-8,000,000-10,000,000-10,000,000-10,000,0000-9,999,700-9,999,700-9,999,700-9,999,700-9,999,700-9,999,700-19,999,70000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,576,989
4,444,821
4,454,984
4,025,088
3,499,655
478,985
438,354
0
0
328,682
0
0
0
178,380
0
0
0
89,190
0
0
0
0
0
0
0
0
0
0
0
0000000000089,190000178,380000328,68200438,354478,9853,499,6554,025,0884,454,9844,444,8214,576,98900000000000000
> Total Stockholder Equity
37,198,610
38,725,149
40,015,897
39,389,594
39,690,488
40,455,814
41,995,495
43,158,272
43,364,008
44,602,368
45,666,174
46,818,068
48,912,850
50,561,599
51,606,929
53,729,451
54,037,843
64,563,318
66,738,303
65,304,181
65,957,661
67,553,268
70,976,327
74,881,568
75,305,846
74,303,189
76,568,931
60,336,288
63,095,266
57,096,011
56,250,297
44,450,939
42,768,835
43,047,333
42,432,966
45,633,897
45,446,102
58,177,743
57,600,013
49,129,169
72,541,045
72,164,194
73,844,804
73,844,80472,164,19472,541,04549,129,16957,600,01358,177,74345,446,10245,633,89742,432,96643,047,33342,768,83544,450,93956,250,29757,096,01163,095,26660,336,28876,568,93174,303,18975,305,84674,881,56870,976,32767,553,26865,957,66165,304,18166,738,30364,563,31854,037,84353,729,45151,606,92950,561,59948,912,85046,818,06845,666,17444,602,36843,364,00843,158,27241,995,49540,455,81439,690,48839,389,59440,015,89738,725,14937,198,610
   Common Stock
4,709,767
4,893,929
4,913,929
4,928,929
4,928,929
4,928,929
4,928,928
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,928,929
4,951,227
4,951,227
4,951,227
4,951,227
4,998,410
5,051,491
5,051,491
5,051,491
5,051,491
5,051,491
5,051,491
5,051,491
5,051,491
5,051,491
5,226,491
0
0
0
0
0
0
0000005,226,4915,051,4915,051,4915,051,4915,051,4915,051,4915,051,4915,051,4915,051,4915,051,4914,998,4104,951,2274,951,2274,951,2274,951,2274,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9294,928,9284,928,9294,928,9294,928,9294,913,9294,893,9294,709,767
   Retained Earnings Total Equity0000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,244,820
14,244,820
27,211,002
14,244,820
16,532,609
19,322,014
19,322,014
19,322,014
19,322,014
19,322,014
19,322,014
19,322,014
19,322,014
19,322,014
22,907,124
0
0
0
0
0
0
00000022,907,12419,322,01419,322,01419,322,01419,322,01419,322,01419,322,01419,322,01419,322,01419,322,01416,532,60914,244,82027,211,00214,244,82014,244,8200000000000000000000000
   Treasury Stock0000000000-884,320-884,320-884,320-884,320-884,320-884,320-884,320-614,0920-130,146-130,14600-130,146-130,146-130,146-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186-1,450,186
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11,040
-9,326
-46,270
-342,418
-323,512
-1,144,355
-1,144,350
-1,133,611
11,834,901
11,800,070
-1,110,315
-1,211,617
-1,154,634
-1,160,054
-1,107,630
251,162
1,228,349
-1,143,132
11,518,594
11,365,644
-1,551,939
-1,936,875
-1,518,449
0
0
0
0
0
0
000000-1,518,449-1,936,875-1,551,93911,365,64411,518,594-1,143,1321,228,349251,162-1,107,630-1,160,054-1,154,634-1,211,617-1,110,31511,800,07011,834,901-1,133,611-1,144,350-1,144,355-323,512-342,418-46,270-9,326-11,04000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-09-30. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue78,032,037
Cost of Revenue-32,908,904
Gross Profit45,123,13345,123,133
 
Operating Income (+$)
Gross Profit45,123,133
Operating Expense-82,186,914
Operating Income-4,154,877-37,063,781
 
Operating Expense (+$)
Research Development5,597,398
Selling General Administrative21,869,845
Selling And Marketing Expenses0
Operating Expense82,186,91427,467,243
 
Net Interest Income (+$)
Interest Income88,127
Interest Expense-5,523,002
Other Finance Cost-1
Net Interest Income-5,434,876
 
Pretax Income (+$)
Operating Income-4,154,877
Net Interest Income-5,434,876
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,532,130-4,154,877
EBIT - interestExpense = -5,523,002
-23,044,679
-17,521,677
Interest Expense5,523,002
Earnings Before Interest and Taxes (EBIT)0-18,009,128
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-23,532,130
Tax Provision-559,586
Net Income From Continuing Ops-24,091,716-24,091,716
Net Income-23,044,679
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net05,434,876
 

Technical Analysis of Hansbiomed
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hansbiomed. The general trend of Hansbiomed is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hansbiomed's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HansBiomed Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10,510 < 11,500 < 11,870.

The bearish price targets are: 8,130 > 6,900 > 6,500.

Tweet this
HansBiomed Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HansBiomed Corporation. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HansBiomed Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HansBiomed Corporation. The current macd is 212.63.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hansbiomed price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hansbiomed. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hansbiomed price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
HansBiomed Corporation Daily Moving Average Convergence/Divergence (MACD) ChartHansBiomed Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HansBiomed Corporation. The current adx is 31.62.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hansbiomed shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
HansBiomed Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HansBiomed Corporation. The current sar is 7,159.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
HansBiomed Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HansBiomed Corporation. The current rsi is 62.69. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
HansBiomed Corporation Daily Relative Strength Index (RSI) ChartHansBiomed Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HansBiomed Corporation. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hansbiomed price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
HansBiomed Corporation Daily Stochastic Oscillator ChartHansBiomed Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HansBiomed Corporation. The current cci is 126.52.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
HansBiomed Corporation Daily Commodity Channel Index (CCI) ChartHansBiomed Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HansBiomed Corporation. The current cmo is 34.83.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
HansBiomed Corporation Daily Chande Momentum Oscillator (CMO) ChartHansBiomed Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HansBiomed Corporation. The current willr is -14.84716157.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
HansBiomed Corporation Daily Williams %R ChartHansBiomed Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HansBiomed Corporation.

HansBiomed Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HansBiomed Corporation. The current atr is 486.68.

HansBiomed Corporation Daily Average True Range (ATR) ChartHansBiomed Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HansBiomed Corporation. The current obv is 4,875,314.

HansBiomed Corporation Daily On-Balance Volume (OBV) ChartHansBiomed Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HansBiomed Corporation. The current mfi is 58.10.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
HansBiomed Corporation Daily Money Flow Index (MFI) ChartHansBiomed Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HansBiomed Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

HansBiomed Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HansBiomed Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.690
Ma 20Greater thanMa 507,938.500
Ma 50Greater thanMa 1008,151.400
Ma 100Greater thanMa 2009,197.300
OpenGreater thanClose8,700.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Hansbiomed with someone you think should read this too:
  • Are you bullish or bearish on Hansbiomed? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hansbiomed? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HansBiomed Corporation

I send you an email if I find something interesting about HansBiomed Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about HansBiomed Corporation.

Receive notifications about HansBiomed Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.